BN101E / BAGI Biosci - LARVOL DELTA

Parianon (01498.HK) spent over 40 million to acquire licensed intellectual property rights and raised 20 million by issuing new shares to third parties. [Google translation] (Yahoo Finance) - "Parianon (01498.HK) announced that it has received a license for the BN101E project's intellectual property rights from BAGI Group, controlled by its Chairman and controlling shareholder, Chen Yuling. The license fee is HK$40.2 million, payable through the issuance of 93.4883 million consideration shares at an issue price of HK$0.43, a 6.52% discount to the previous trading day's closing price (25th). The BN101E project, based on patented technology, focuses on developing anti-inflammatory botanical drugs for the treatment of rheumatoid arthritis."

Licensing / partnership • Rheumatoid Arthritis